4-Hydroxyfurano[2\'\',3\'\':6,7]aurone



Compound IDCDAMM02856
Common name4-Hydroxyfurano[2\'\',3\'\':6,7]aurone
IUPAC name2-benzylidene-3-hydroxyfuro[2,3-g][1]benzofuran-4-one
Molecular formulaC17H10O4

Experimental data

Retention time7.38
Adduct[M+H]+
Actual mz279.062
Theoretical mz279.065
Error11.02
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.8572

Identifiers and class information

Inchi keyNULUMMBDIFUOPU-UHFFFAOYSA-N
SmilesO=C1C(OC2=C3C=COC3=CC(O)=C12)=CC=4C=CC=CC4
SuperclassPhenylpropanoids and polyketides
ClassAurone flavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)3
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)278.264
Computed dipole moment(dipole)8.025
Total solvent accessible surface area (SASA)497.849
Hydrophobic component of SASA (FOSA)11.696
Hydrophilic component of SASA (FISA)98.43
Pie component of the SASA (PISA)387.723
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)841.96
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)2.75
Free energy of solvation of dipole (dip^2/V)0.0764895
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.866154
Predicted polarizability in cubic angstroms (QPpolrz)29.318
Predicted hexadecane/gas partition coefficient (QPlogPC16)9.45
Predicted octanol/gas partition coefficient (QPlogPoct)12.148
Predicted water/gas partition coefficient (QPlogPw)6.271
Predicted octanol/water partition coefficient (QPlogPo/w)3.222
Predicted aqueous solubility (QPlogS)-3.723
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.786
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.547
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1154.76
Predicted brain/blood partition coefficient (QPlogBB)-0.492
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)577.956
Predicted skin permeability, log Kp (QPlogKp)-1.68
PM3 calculated ionization potential (IP(ev))8.045
PM3 calculated electron affinity (EA(eV))1.889
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)0.199
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)66.476
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P21397MAOAMonoamine oxidase AT83875SEA
P27338MAOBMonoamine oxidase BT83011SEA
P22001KCNA3Voltage-gated potassium channel subunit Kv1.3T76914SEA
Q92952KCNN1Small conductance calcium-activated potassium channel protein 1T11911SEA
Q9H2S1KCNN2Small conductance calcium-activated potassium channel protein 2T86271SEA
Q92887CMOATMultidrug resistance-associated protein 2T61792SEA
Q96HK3CALMCalmodulinT39610SEA
Q09470KCNA1Voltage-gated potassium channel Kv1.1T85272SEA
Q96RP8KCNA7Voltage-gated potassium channel Kv1.7T84737SEA
P22459KCNA4Voltage-gated A-type potassium channelT15665SEA
P16389KCNA2Voltage-gated potassium channel Kv1.2T19492SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83875DI0117Depression[ICD-11: 6A70-6A7Z]P21397MAOA
T83875DI0331Parkinsonism[ICD-11: 8A00]P21397MAOA
T83011DI0115Dementia[ICD-11: 6D80-6D8Z]P27338MAOB
T83011DI0117Depression[ICD-11: 6A70-6A7Z]P27338MAOB
T83011DI0190Hypertension[ICD-11: BA00-BA04]P27338MAOB
T83011DI0243Malaria[ICD-11: 1F40-1F45]P27338MAOB
T83011DI0264Migraine[ICD-11: 8A80]P27338MAOB
T83011DI0331Parkinsonism[ICD-11: 8A00]P27338MAOB
T76914DI0198Idiopathic inflammatory myopathy[ICD-11: 4A41]P22001KCNA3
T76914DI0351Psoriasis[ICD-11: EA90]P22001KCNA3
T76914DI0352Psoriatic arthritis[ICD-11: FA21]P22001KCNA3
T11911DI0285Myelopathy[ICD-11: 8B42]Q92952KCNN1
T86271DI0285Myelopathy[ICD-11: 8B42]Q9H2S1KCNN2
T39610DI0068Cardiac arrhythmia[ICD-11: BC9Z]Q96HK3CALM
T39610DI0243Malaria[ICD-11: 1F40-1F45]Q96HK3CALM
T39610DI0370Schizophrenia[ICD-11: 6A20]Q96HK3CALM

Copyright © 2025